Filing Flows › Quest Diagnostics (DGX) › Free cash flow
Quest Diagnostics (DGX) free cash flow by quarter
Quest Diagnostics' free cash flow was $445M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $164M (Q1 2026) to $459M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $445M | -3% | +6% |
| Q2 2026 | $459M | +180% | +5% |
| Q1 2026 | $164M | -47% | -17% |
| Q4 2025 | $307M | -27% | — |
| Q3 2025 | $419M | -4% | — |
| Q2 2025 | $436M | +121% | — |
| Q1 2025 | $197M | — | — |
Q3 2026 at a glance
Quest Diagnostics, Q3 2026: revenue $3.1B (+10% year over year), operating margin 15.5%, net earnings $312M, operating cash flow $611M. The chart follows the revenue to costs, profit and cash.
Questions
What is Quest Diagnostics' free cash flow?
Quest Diagnostics' free cash flow was $445M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Quest Diagnostics' free cash flow changed?
Over the last 7 quarters it ranged from $164M (Q1 2026) to $459M (Q2 2026).